Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial.
Motovska Z, Hlinomaz O, Mrozek J, Kala P, Geisler T, Hromadka M, Akin I, Precek J, Kettner J, Cervinka P, Montalescot G, Jarkovsky J, Belohlavek J, Bis J, Matejka J, Vodzinska A, Muzafarova T, Tomasov P, Schee A, Bartus S, Andrasova A, Olivier CB, Kovarik A, Ostadal P, Demlova R, Souckova L, Vulev I, Coufal Z, Kochman J, Marinov I, Kubica J, Ducrocq G, Karpisek M, Klimsa Z, Hudec M, Widimsky P, Bhatt DL, Group DS. Motovska Z, et al. Among authors: hlinomaz o. EuroIntervention. 2024 Oct 21;20(20):e1309-e1318. doi: 10.4244/EIJ-D-24-00203. EuroIntervention. 2024. PMID: 39432252 Free article.
Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.
Motovska Z, Hlinomaz O, Miklik R, Hromadka M, Varvarovsky I, Dusek J, Knot J, Jarkovsky J, Kala P, Rokyta R, Tousek F, Kramarikova P, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group. Motovska Z, et al. Among authors: hlinomaz o. Circulation. 2016 Nov 22;134(21):1603-1612. doi: 10.1161/CIRCULATIONAHA.116.024823. Epub 2016 Aug 30. Circulation. 2016. PMID: 27576777 Clinical Trial.
The prognostic significance of periprocedural infarction in the era of potent antithrombotic therapy. The PRAGUE-18 substudy.
Dusek J, Motovska Z, Hlinomaz O, Miklik R, Hromadka M, Varvarovsky I, Jarkovsky J, Tousek F, Majtan B, Simek S, Branny M, Mrozek J, Widimsky P; Prague-18 Study Group. Dusek J, et al. Among authors: hlinomaz o. Int J Cardiol. 2020 Nov 15;319:1-6. doi: 10.1016/j.ijcard.2020.06.067. Epub 2020 Jul 4. Int J Cardiol. 2020. PMID: 32634499
The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI: Observations from Prague-18 Study.
Hromadka M, Motovska Z, Hlinomaz O, Kala P, Varvarovsky I, Dusek J, Svoboda M, Jarkovsky J, Tousek F, Jansky P, Simek S, Branny M, Mrozek J, Miklik R, Rokyta R, Widimsky P. Hromadka M, et al. Among authors: hlinomaz o. J Cardiol. 2022 May;79(5):626-633. doi: 10.1016/j.jjcc.2021.11.015. Epub 2021 Dec 16. J Cardiol. 2022. PMID: 34924237 Free article. Clinical Trial.
Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry.
Knot J, Kala P, Rokyta R, Stasek J, Kuzmanov B, Hlinomaz O, Bĕlohlavek J, Rohac FP, Petr R, Bilkova D, Djambazov S, Grigorov M, Widimsky P. Knot J, et al. Among authors: hlinomaz o. Cardiovasc J Afr. 2012 Oct;23(9):495-500. doi: 10.5830/CVJA-2012-053. Cardiovasc J Afr. 2012. PMID: 23108517 Free PMC article.
Response by Motovska et al to Letter Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study".
Motovska Z, Hlinomaz O, Kala P; PRAGUE-18 Investigators. Motovska Z, et al. Among authors: hlinomaz o. Circulation. 2017 Apr 11;135(15):e887-e888. doi: 10.1161/CIRCULATIONAHA.117.027476. Circulation. 2017. PMID: 28396383 No abstract available.
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor.
Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Jarkovsky J, Miklik R, Rokyta R, Tousek F, Kramarikova P, Svoboda M, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group. Motovska Z, et al. Among authors: hlinomaz o. J Am Coll Cardiol. 2018 Jan 30;71(4):371-381. doi: 10.1016/j.jacc.2017.11.008. Epub 2017 Nov 14. J Am Coll Cardiol. 2018. PMID: 29154813 Free article. Clinical Trial.
The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy.
Simek S, Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Rokyta R, Tousek F, Svoboda M, Vodzinska A, Mrozek J, Jarkovsky J, On Behalf Of The Prague-Study Group. Simek S, et al. Among authors: hlinomaz o. J Clin Med. 2020 Aug 6;9(8):2555. doi: 10.3390/jcm9082555. J Clin Med. 2020. PMID: 32781780 Free PMC article.
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
Silvain J, Lattuca B, Beygui F, Rangé G, Motovska Z, Dillinger JG, Boueri Z, Brunel P, Lhermusier T, Pouillot C, Larrieu-Ardilouze E, Boccara F, Labeque JN, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Collet JP, Cayla G, Blanchart K, Kala P, Vicaut E, Montalescot G; ALPHEUS investigators. Silvain J, et al. Lancet. 2020 Nov 28;396(10264):1737-1744. doi: 10.1016/S0140-6736(20)32236-4. Epub 2020 Nov 14. Lancet. 2020. PMID: 33202219 Free article. Clinical Trial.
88 results